Literature DB >> 9489202

Horizontal transmission of hepatitis B in a children's day-care centre: a preventable event.

E D McIntosh1, M D Bek, M Cardona, K Goldston, D Isaacs, M A Burgess, Y E Cossart.   

Abstract

Using molecular finger-printing, we provided evidence that, in a children's day-care centre, a known hepatitis B virus (HBV) hepatitis B e antigen (HBeAg) carrier transmitted HBV to another child (the index case). The chronic HBV carrier had an exudative skin lesion and a history of biting. We sought to identify other at-risk children and prevent further transmission. Blood samples were collected and tested serologically for HBV. Of the 90 other children, 78 (87 per cent) were tested and none had serological evidence of HBV infection; 73 (81 per cent) were of Caucasian background; 38 (49 per cent) had a history of HBV immunisation with serological confirmation. Therefore, 1 (2.4 per cent, 95 per cent confidence interval 1.0 to 12.8 per cent) of the 41 known susceptible contacts became infected. The risk of horizontal HBV transmission in a children's day-care centre is low but not negligible. Staff and children should be vaccinated when a child in a day-care centre is a known HBV carrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9489202     DOI: 10.1111/j.1467-842x.1997.tb01797.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  3 in total

1.  Hepatitis B in childhood: An update for the paediatrician.

Authors:  L T Yeung; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

2.  A bite in the playroom: Managing human bites in child care settings.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

3.  A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon.

Authors:  Anfumbom Kw Kfutwah; Mathurin Cyrille Tejiokem; Richard Njouom
Journal:  Virol J       Date:  2012-03-08       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.